Sunny Kim

Sunny Kim has an extensive background in biochemistry and biotechnology, with over 15 years of experience in next-generation sequencing (NGS) platforms and consumables. They have held various leadership roles in process development, strategic sourcing, and research at companies like Element Biosciences, Singular Genomics, Hologic, and Pacific Biosciences. Sunny's expertise includes managing teams, leading collaborations with engineers and scientists, and launching new products in the biotech industry. They have a Ph.D. in Biochemistry from Stanford University School of Medicine and a ScB in Biochemistry from Brown University.